APP and Alzheimer disease: Meanwhile, the PDE8 inhibitor PF modulated microglial reprogramming, inhibited microglia with a proinflammatory state polarization, and limited the release of inflammatory cytokines in the hippocampus of AβO-induced AD model and APP/PS1 mice.